MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation

BackgroundHepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of down...

Full description

Bibliographic Details
Main Authors: Yinghui Hong, Mingliang Ye, Fan Wang, Jun Fang, Chun Wang, Jie Luo, Jialiang Liu, Jing Liu, Lan Liu, Qiu Zhao, Ying Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.642030/full
id doaj-dcd43bfb2def46988680dea0f4cbfc27
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yinghui Hong
Yinghui Hong
Mingliang Ye
Mingliang Ye
Fan Wang
Fan Wang
Jun Fang
Jun Fang
Chun Wang
Chun Wang
Jie Luo
Jie Luo
Jialiang Liu
Jialiang Liu
Jing Liu
Jing Liu
Lan Liu
Lan Liu
Qiu Zhao
Qiu Zhao
Ying Chang
Ying Chang
spellingShingle Yinghui Hong
Yinghui Hong
Mingliang Ye
Mingliang Ye
Fan Wang
Fan Wang
Jun Fang
Jun Fang
Chun Wang
Chun Wang
Jie Luo
Jie Luo
Jialiang Liu
Jialiang Liu
Jing Liu
Jing Liu
Lan Liu
Lan Liu
Qiu Zhao
Qiu Zhao
Ying Chang
Ying Chang
MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
Frontiers in Oncology
MiR-21-3p
hepatocellular carcinoma
SMAD7
YAP1
prognosis
author_facet Yinghui Hong
Yinghui Hong
Mingliang Ye
Mingliang Ye
Fan Wang
Fan Wang
Jun Fang
Jun Fang
Chun Wang
Chun Wang
Jie Luo
Jie Luo
Jialiang Liu
Jialiang Liu
Jing Liu
Jing Liu
Lan Liu
Lan Liu
Qiu Zhao
Qiu Zhao
Ying Chang
Ying Chang
author_sort Yinghui Hong
title MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_short MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_full MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_fullStr MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_full_unstemmed MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_sort mir-21-3p promotes hepatocellular carcinoma progression via smad7/yap1 regulation
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-03-01
description BackgroundHepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression.AimsHere, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis.MethodsMiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance.ResultsMiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC.ConclusionMiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC.
topic MiR-21-3p
hepatocellular carcinoma
SMAD7
YAP1
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.642030/full
work_keys_str_mv AT yinghuihong mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT yinghuihong mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT mingliangye mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT mingliangye mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT fanwang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT fanwang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT junfang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT junfang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT chunwang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT chunwang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jieluo mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jieluo mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jialiangliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jialiangliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jingliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT jingliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT lanliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT lanliu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT qiuzhao mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT qiuzhao mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT yingchang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT yingchang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
_version_ 1724229136912744448
spelling doaj-dcd43bfb2def46988680dea0f4cbfc272021-03-08T05:46:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.642030642030MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 RegulationYinghui Hong0Yinghui Hong1Mingliang Ye2Mingliang Ye3Fan Wang4Fan Wang5Jun Fang6Jun Fang7Chun Wang8Chun Wang9Jie Luo10Jie Luo11Jialiang Liu12Jialiang Liu13Jing Liu14Jing Liu15Lan Liu16Lan Liu17Qiu Zhao18Qiu Zhao19Ying Chang20Ying Chang21Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, ChinaClinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan University, Wuhan, ChinaBackgroundHepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression.AimsHere, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis.MethodsMiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance.ResultsMiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC.ConclusionMiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC.https://www.frontiersin.org/articles/10.3389/fonc.2021.642030/fullMiR-21-3phepatocellular carcinomaSMAD7YAP1prognosis